RTI-HS has an established US Payer Advisory Council and access to a network of international P&R experts to ensure that our evaluations and product strategies are grounded and payer relevant. The Advisory Boards provide an important tool for assessing pricing, reimbursement & market access opportunities and risks. We have various approaches (e.g., in person vs “virtual” ad boards) and we have experience in market-specific payer (and other stakeholder) ad boards as well as global ad boards that aim to provide global efficiencies in evidence development and ID market-specific barriers.
